1-47251517-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001048166.1(STIL):​c.3486T>C​(p.Pro1162Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.499 in 1,613,978 control chromosomes in the GnomAD database, including 207,731 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1162P) has been classified as Benign.

Frequency

Genomes: 𝑓 0.43 ( 15910 hom., cov: 33)
Exomes 𝑓: 0.51 ( 191821 hom. )

Consequence

STIL
NM_001048166.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.821

Publications

17 publications found
Variant links:
Genes affected
STIL (HGNC:10879): (STIL centriolar assembly protein) This gene encodes a cytoplasmic protein implicated in regulation of the mitotic spindle checkpoint, a regulatory pathway that monitors chromosome segregation during cell division to ensure the proper distribution of chromosomes to daughter cells. The protein is phosphorylated in mitosis and in response to activation of the spindle checkpoint, and disappears when cells transition to G1 phase. It interacts with a mitotic regulator, and its expression is required to efficiently activate the spindle checkpoint. It is proposed to regulate Cdc2 kinase activity during spindle checkpoint arrest. Chromosomal deletions that fuse this gene and the adjacent locus commonly occur in T cell leukemias, and are thought to arise through illegitimate V-(D)-J recombination events. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
STIL Gene-Disease associations (from GenCC):
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • microcephaly 7, primary, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • holoprosencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-47251517-A-G is Benign according to our data. Variant chr1-47251517-A-G is described in ClinVar as Benign. ClinVar VariationId is 94095.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.821 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.533 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STILNM_001048166.1 linkc.3486T>C p.Pro1162Pro synonymous_variant Exon 17 of 17 ENST00000371877.8 NP_001041631.1 Q15468-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STILENST00000371877.8 linkc.3486T>C p.Pro1162Pro synonymous_variant Exon 17 of 17 1 NM_001048166.1 ENSP00000360944.3 Q15468-2

Frequencies

GnomAD3 genomes
AF:
0.426
AC:
64739
AN:
152016
Hom.:
15893
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.171
Gnomad AMI
AF:
0.467
Gnomad AMR
AF:
0.431
Gnomad ASJ
AF:
0.656
Gnomad EAS
AF:
0.447
Gnomad SAS
AF:
0.549
Gnomad FIN
AF:
0.645
Gnomad MID
AF:
0.528
Gnomad NFE
AF:
0.522
Gnomad OTH
AF:
0.460
GnomAD2 exomes
AF:
0.502
AC:
126084
AN:
251182
AF XY:
0.512
show subpopulations
Gnomad AFR exome
AF:
0.161
Gnomad AMR exome
AF:
0.443
Gnomad ASJ exome
AF:
0.649
Gnomad EAS exome
AF:
0.450
Gnomad FIN exome
AF:
0.650
Gnomad NFE exome
AF:
0.525
Gnomad OTH exome
AF:
0.534
GnomAD4 exome
AF:
0.507
AC:
741146
AN:
1461842
Hom.:
191821
Cov.:
65
AF XY:
0.510
AC XY:
371022
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.153
AC:
5130
AN:
33480
American (AMR)
AF:
0.441
AC:
19724
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.644
AC:
16827
AN:
26132
East Asian (EAS)
AF:
0.418
AC:
16606
AN:
39694
South Asian (SAS)
AF:
0.537
AC:
46296
AN:
86252
European-Finnish (FIN)
AF:
0.640
AC:
34159
AN:
53412
Middle Eastern (MID)
AF:
0.526
AC:
3032
AN:
5768
European-Non Finnish (NFE)
AF:
0.512
AC:
568952
AN:
1111984
Other (OTH)
AF:
0.504
AC:
30420
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
23313
46625
69938
93250
116563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16260
32520
48780
65040
81300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.426
AC:
64782
AN:
152136
Hom.:
15910
Cov.:
33
AF XY:
0.432
AC XY:
32106
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.171
AC:
7105
AN:
41538
American (AMR)
AF:
0.431
AC:
6583
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.656
AC:
2277
AN:
3470
East Asian (EAS)
AF:
0.447
AC:
2314
AN:
5172
South Asian (SAS)
AF:
0.551
AC:
2652
AN:
4814
European-Finnish (FIN)
AF:
0.645
AC:
6810
AN:
10556
Middle Eastern (MID)
AF:
0.541
AC:
159
AN:
294
European-Non Finnish (NFE)
AF:
0.522
AC:
35480
AN:
67986
Other (OTH)
AF:
0.463
AC:
976
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1711
3421
5132
6842
8553
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
608
1216
1824
2432
3040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.485
Hom.:
10099
Bravo
AF:
0.396
Asia WGS
AF:
0.492
AC:
1709
AN:
3478
EpiCase
AF:
0.530
EpiControl
AF:
0.526

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 03, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 18, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Microcephaly 7, primary, autosomal recessive Benign:3
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.1
DANN
Benign
0.45
PhyloP100
-0.82
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2758735; hg19: chr1-47717189; COSMIC: COSV108067324; API